These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1189 related articles for article (PubMed ID: 36620648)

  • 21. Relationship of changes in QRS duration with left ventricular ejection fraction in patients with acute ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Wang K; Wang L; He F; Li H; Fang Y; Hu G; Wang X
    Heliyon; 2024 Aug; 10(15):e35078. PubMed ID: 39165983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of platelet/lymphocyte ratio and CAMI-STEMI score for major adverse cardiac events in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: A prospective observational study.
    Wang Y; Peng Z
    Medicine (Baltimore); 2021 Aug; 100(33):e26942. PubMed ID: 34414954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention.
    Liu HW; Han YL; Jin QM; Wang XZ; Ma YY; Wang G; Wang B; Xu K; Li Y; Chen SL
    Chin Med J (Engl); 2018 Jun; 131(12):1412-1419. PubMed ID: 29893357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nomogram for Predicting In-Hospital Mortality in Patients with Acute ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock after Primary Percutaneous Coronary Intervention.
    Wang Y; Liu L; Li X; Dang Y; Li Y; Wang J; Qi X
    J Interv Cardiol; 2022; 2022():8994106. PubMed ID: 35356419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of three Inflammation-based Glasgow Prognostic Scores for major cardiovascular adverse events in patients with acute myocardial infarction during hospitalization: a retrospective study.
    Zhu H; Li Z; Xu X; Fang X; Chen T; Huang J
    PeerJ; 2020; 8():e9068. PubMed ID: 32355581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A radiomic nomogram for prediction of major adverse cardiac events in ST-segment elevation myocardial infarction.
    Ma Q; Ma Y; Wang X; Li S; Yu T; Duan W; Wu J; Wen Z; Jiao Y; Sun Z; Hou Y
    Eur Radiol; 2021 Feb; 31(2):1140-1150. PubMed ID: 32856164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive Value of the Lipoprotein(a) to Prealbumin Ratio and of the NT-proBNP to LVEF Ratio for Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome.
    Zhang Y; Shi F
    Heart Surg Forum; 2023 Oct; 26(5):E470-E477. PubMed ID: 37920075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction and validation of nomogram model for predicting the risk of ventricular arrhythmia after emergency PCI in patients with acute myocardial infarction.
    Wang W; Chen M; Guo J; Wang Y; Zhang J
    Aging (Albany NY); 2024 May; 16(9):8246-8259. PubMed ID: 38742959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A nomogramic model for predicting the left ventricular ejection fraction of STEMI patients after thrombolysis-transfer PCI.
    Liu S; Jiang Z; Zhang Y; Pang S; Hou Y; Liu Y; Huang Y; Peng N; Tang Y
    Front Cardiovasc Med; 2023; 10():1178417. PubMed ID: 37745105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a nomogram for the prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary percutaneous coronary intervention: a multicentre, retrospective, observational study in Hebei province, China.
    Wang Y; Wang W; Jia S; Gao M; Zheng S; Wang J; Dang Y; Li Y; Qi X
    BMJ Open; 2022 Feb; 12(2):e056101. PubMed ID: 35110324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A nomogram for predicting the risk of no-reflow after primary percutaneous coronary intervention in elderly patients with ST-segment elevation myocardial infarction.
    Yang L; Cong H; Lu Y; Chen X; Liu Y
    Ann Transl Med; 2021 Jan; 9(2):126. PubMed ID: 33569428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors and prediction nomogram model for 1-year readmission for major adverse cardiovascular events in patients with STEMI after PCI.
    Yao W; Li J
    Clin Appl Thromb Hemost; 2022; 28():10760296221137847. PubMed ID: 36380508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of selected cardiovascular factors on mortality in patients with ST-segment elevation myocardial infarction treated with primary coronary intervention.
    Komorova Z; Machal J; Groch L; Spinarova L; Labr K
    Bratisl Lek Listy; 2023; 124(6):421-426. PubMed ID: 36876376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central arterial pressure predicts in-hospital major adverse cardiovascular events after acute ST-segment elevation myocardial infarction: a retrospective cohort study.
    Zhang L; Wang Z; Lu X; Gan F
    Ann Transl Med; 2023 Mar; 11(5):214. PubMed ID: 37007547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the Predicting Value of Neutrophil to high-Density Lipoprotein Cholesterol Ratio and Monocyte to high-Density Lipoprotein Cholesterol Ratio for in-Hospital Prognosis and Severe Coronary Artery Stenosis in Patients with ST-Segment Elevation Acute Myocardial Infarction Following Percutaneous Coronary Intervention: A Retrospective Study.
    Guo J; Chen M; Hong Y; Huang Y; Zhang H; Zhou Y; Zhou B; Fu M
    J Inflamm Res; 2023; 16():4541-4557. PubMed ID: 37868828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study.
    Qin Z; Du Y; Zhou Q; Lu X; Luo L; Zhang Z; Guo N; Ge L
    Cardiol Res Pract; 2021; 2021():9943668. PubMed ID: 34765262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prognostic nomogram for long-term major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention.
    Kong S; Chen C; Zheng G; Yao H; Li J; Ye H; Wang X; Qu X; Zhou X; Lu Y; Zhou H
    BMC Cardiovasc Disord; 2021 May; 21(1):253. PubMed ID: 34022791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and validation of a predictive model for adverse left ventricular remodeling in NSTEMI patients after primary percutaneous coronary intervention.
    Wang L; Liu T; Wang C; Xuan H; Xu X; Yin J; Li X; Chen J; Li D; Xu T
    BMC Cardiovasc Disord; 2022 Aug; 22(1):386. PubMed ID: 36030211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of a nomogram to predict the five-year risk of revascularization for non-culprit lesion progression in STEMI patients after primary PCI.
    Dai F; Xu X; Zhou C; Li C; Tian Z; Wang Z; Yang S; Liao G; Shi X; Wang L; Li D; Hou X; Chen J; Xu T
    Front Cardiovasc Med; 2023; 10():1275710. PubMed ID: 38094123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.